Retatrutide, an investigational triple agonist for GLP-1, GIP, and glucagon receptors, enhances metabolic regulation by amplifying insulin secretion, suppressing appetite, and increasing energy expenditure through cAMP-mediated signaling. Its multi-receptor approach promotes significant weight loss and improves glucose control, potentially surpassing dual agonists like Tirzepatide.
Brand: Cell Energix
| Unit Size | 10 mg/vial |
| Unit Quantity | 1 Amber Vial |
| Molecular Formula | C46H56N10O9 |
| Molecular Weight | 888.01 |
| Sequence | H-Arg-D-Ala-His-D-Phe-Ser-Tyr-Gly-Pro-Lys(1)-OH |
| Appearance | White Powder |
| Peptide Purity | >98.1% |
| Solubility | Soluble in water or 1% acetic acid |
.
Retatrutide Sequence:
7
The products offered on this website are furnished for in-vitro studies (Latin:in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
